Life sciences

Antibody drug conjugate
#Antibody drug conjugate (ADC) #Drug discovery #Investment #Life sciences #Oncology

Bead BioPharma emerges from stealth with novel drug platform 

Bead BioPharma has emerged from stealth by submitting a patent for a novel cancer drug platform.  The life sciences company, backed by Archangels, submitted the patent in efforts to launch its formal entry into one of the most competitive sectors of global oncology.  Bead BioPharma is focused on antibody-drug conjugates (ADCs), a… Read More

#Business & Investment #News

MHRA
#Life sciences #MHRA #Northern Ireland

MHRA to open Northern Ireland hub to boost life sciences 

The Medicines and Healthcare products Regulatory Agency (MHRA) is opening a new hub in Northern Ireland to boost life sciences growth in the country.  The hub, hosted by Invest Northern Ireland, aims to build on MHRA’s partnerships in healthcare, academia and industry in… Read More

#News #Regulatory

UK
#ABPI #AstraZeneca #Life sciences #UK

AstraZeneca investment strengthens UK’s position, CEO says 

AstraZeneca’s investment U-turn shows the UK is “a global destination for life sciences investment”, the ABPI’s Chief Executive has said.  Richard Torbett was speaking after AstraZeneca announced it would resume large-scale activity in the UK with a £300 million ($405 million) investment. The drugmaker had previously rolled back… Read More

#Business & Investment #News

#AI #Life sciences #Pistoia Alliance #R&D

Use of AI in drug R&D limited in life sciences, survey says 

The use of artificial intelligence is widespread across life sciences organisations but its use in drug research and development is limited, analysis finds.  Research by The Pistoia Alliance, a not-for-profit life sciences advocacy group, shows 30% of life sciences professionals say their organisation has implemented an enterprise-wide AI… Read More

#News

Science connection and networking
#BioTrinity #Life sciences

OBN rebrands as BioUK to capitalise on life sciences success 

OBN has rebranded to BioUK to reflect its goal of catalysing on success in the UK life sciences sector.  The not-for-profit organisation says the updated brand identity has been developed to align with its position following a period of sustained growth, providing support throughout the UK to help R&D… Read More

#News

#Life sciences #UK

Construction completed on new UK life science facility 

Construction of a 56,000 sq ft UK life science facility has been completed, Aviva Investors has announced.  Chesterford Research Park, owned by Aviva Investors, now includes ten fully-fitted research and development suites spread over three floors, bringing capacity to approximately 385,000 sq ft of net internal space to UK life science… Read More

#News

Flow cytometry
#Life sciences #Waters Corporation

Waters merges with BD Biosciences and Diagnostic Solutions 

Life science and diagnostics company Waters has announced its combination with BD Biosciences and Diagnostic Solutions to form a unified company.  The company aims to be a global leader in life sciences and diagnostics, having established a portfolio spanning liquid chromatography, mass spectrometry, materials characterisation, flow cytometry, and diagnostic… Read More

#News

Artificial intelligence
#AI #Life sciences #SLAS2026

Cenevo launches AI agents to accelerate lab operations 

Cenevo has advanced towards agentic labs with the launch of two new AI agents.  The company, which specialises in lab management systems, automation, orchestration, data management and AI technology for life sciences, hopes the new agents will help scientists operate faster, smarter and with less manual overhead.  The first new agent,… Read More

#News

#Alzheimer's #Bacteria #Brain cancer #Cancer immunotherapy #Clinical trial #Drug resistance #Fast Track designation #FDA #Gene therapy #Life sciences #Melanoma #Siren Biotechnology #UK government #University of Sydney

DDW Highlights: 10 February 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, innovative therapies showed the way to more effective cancer treatments. Elsewhere, how can… Read More

#Podcasts

#Alzheimer's #Bacteria #Brain cancer #Cancer immunotherapy #Clinical trial #Drug resistance #Fast Track designation #FDA #Gene therapy #Life sciences #Melanoma #Siren Biotechnology #UK #UK government #University of Sydney

This week in Drug Discovery (2 – 6 February) 

News round-up for 2 – 6 February by Bruno Quinney, Content Team at DDW.  This week in DDW, innovative therapies could pave the way to more effective cancer treatments. Elsewhere, how can brain function be improved in Alzheimer’s patients?  The top stories:      Immunotherapy before surgery… Read More

#News

Downing Street, London, UK
#BioIndustry Association #Life sciences #UK #UK government

UK government commits £1.5bn to life sciences  

The UK government has pledged £1.5 billion ($2.1 billion) for R&D in life sciences over the next four years.  Speaking at the BioIndustry Association (BIA)’s Gala Dinner, Liz Kendall, the Secretary of State for Science, Innovation and Technology, confirmed the funding for life sciences as part of the government’s… Read More

#News

#Drug discovery #Legal action #Life sciences #Regulatory

Proactive and forward-looking disclosure risks for pharma

Jennifer Windom, Partner at Hogan Lovells, and Bolton Smith, associate at Hogan Lovells, present the risks and considerations pharmaceutical and life sciences companies have to take when making proactive and forward-looking disclosure statements.  Publicly-traded pharmaceutical and life science companies often face a dilemma when addressing future prospects. On the one… Read More

#Exclusive Content

European map
#BioInnovation Institute #Denmark #Europe #Life sciences #Novo Nordisk Foundation

Novo Nordisk Foundation pledges €736m for scientific innovation 

The Novo Nordisk Foundation has granted DKK 5.5 billion (€736 million) to the BioInnovation Institute (BII) to support life sciences and scientific innovation in Denmark and Europe.  The funding will enable BII to expand its activities into new strategic areas and geographies, supporting even more entrepreneurs and start-up-companies.  … Read More

#Business & Investment #News

#Biosciences #Fujifilm #Life sciences

FUJIFILM Irvine Scientific announces rebrand 

FUJIFILM Irvine Scientific has rebranded as FUJIFILM Biosciences, a decision the company hopes will build on FUJIFILM’s work in the life science industry.  FUJIFILM Biosciences has pledged to continue its customer-focus, empowering scientists and researchers at every stage of discovery, development, and commercialisation. By offering a products and services… Read More

#Business & Investment #News

Quantum computing
#Artificial intelligence (AI) #Biotech #Life sciences #Quantum computing

Quantum-biotech partnership to develop next-gen therapeutics  

Quantum company IonQ has partnered with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutics using hybrid quantum and quantum-AI technologies.  The collaboration will initially focus on areas including bioprocess optimisation, disease-modelling workflows, and quantum-enhanced simulation to support the design and manufacturing of advanced therapies. By… Read More

#Business & Investment #News

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

DDW Highlights: 18 November 2025

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, groundbreaking research showed the Covid-19 mRNA vaccine could boost cancer response. Elsewhere,… Read More

#Podcasts